[go: up one dir, main page]

AU2002236683A1 - Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates - Google Patents

Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates

Info

Publication number
AU2002236683A1
AU2002236683A1 AU2002236683A AU3668302A AU2002236683A1 AU 2002236683 A1 AU2002236683 A1 AU 2002236683A1 AU 2002236683 A AU2002236683 A AU 2002236683A AU 3668302 A AU3668302 A AU 3668302A AU 2002236683 A1 AU2002236683 A1 AU 2002236683A1
Authority
AU
Australia
Prior art keywords
bisphosphonates
vivo
modified
osteoblastic activity
isotopic detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002236683A
Inventor
John V. Frangioni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc filed Critical Beth Israel Deaconess Medical Center Inc
Publication of AU2002236683A1 publication Critical patent/AU2002236683A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002236683A 2000-10-27 2001-10-29 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates Abandoned AU2002236683A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24402000P 2000-10-27 2000-10-27
US60/244,020 2000-10-27
PCT/US2001/051312 WO2002038190A2 (en) 2000-10-27 2001-10-29 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates

Publications (1)

Publication Number Publication Date
AU2002236683A1 true AU2002236683A1 (en) 2002-05-21

Family

ID=22921068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002236683A Abandoned AU2002236683A1 (en) 2000-10-27 2001-10-29 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates

Country Status (4)

Country Link
US (5) US6869593B2 (en)
EP (1) EP1341557A2 (en)
AU (1) AU2002236683A1 (en)
WO (1) WO2002038190A2 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038190A2 (en) * 2000-10-27 2002-05-16 Beth Israel Deaconess Medical Center Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
EP1221465A1 (en) 2001-01-03 2002-07-10 Innosense S.r.l. Symmetric, monofunctionalised polymethine dyes labelling reagents
JP2005507857A (en) * 2001-02-07 2005-03-24 ベズ イズレイル ディーコネス メディカル センター Modified PSMA ligands and uses related thereto
US20040073120A1 (en) * 2002-04-05 2004-04-15 Massachusetts Institute Of Technology Systems and methods for spectroscopy of biological tissue
CA2939460C (en) * 2002-10-10 2019-01-22 Visualsonics Inc. Integrated multi-rail imaging system
US8078256B2 (en) 2002-10-10 2011-12-13 Visualsonics Inc. Integrated multi-rail imaging system
EA009386B1 (en) * 2003-01-24 2007-12-28 Шеринг Акциенгезельшафт Hydrophilic, thiol-reactive cyanine dyes and conjugates thereof with biomolecules for fluorescence diagnosis
GB0311406D0 (en) 2003-05-17 2003-06-25 Queen Mary & Westfield College Substituted phosphonate fluorescent sensors,and use thereof
EP1508348A1 (en) * 2003-08-18 2005-02-23 Medtronic Vascular, Inc. A process for producing a hyper-elastic, high strength dilation balloon made from multi-block copolymers
US20110197556A1 (en) 2004-11-02 2011-08-18 Baldwin Filters, Inc. Filter element
CN1693415B (en) * 2005-04-29 2011-04-13 同济大学 Hydroxy phosphorite of near infrared fluorescence quantum point mark and its preparation process and application
WO2006121920A2 (en) * 2005-05-05 2006-11-16 Beth Israel Deaconess Medical Center, Inc. Micro-scale resonant devices and methods of use
CA2621137C (en) * 2005-09-02 2014-07-29 Visen Medical, Inc. Biocompatible n,n-disubstituted sulfonamide-containing fluorescent dye labels
ES2612738T3 (en) * 2005-09-02 2017-05-18 Visen Medical, Inc. Biocompatible fluorescent imaging agents
JP5416970B2 (en) 2005-09-02 2014-02-12 ビセン メディカル， インコーポレイテッド Nicotinic acid and picolinic acid-derived near-infrared fluorophores
WO2007136413A2 (en) 2005-12-22 2007-11-29 Visen Medical, Inc. Biocompatible fluorescent metal oxide nanoparticles
US7865226B2 (en) * 2006-02-03 2011-01-04 Chiodo Chris D Specimen positioning system for imaging machines
DE102006030382A1 (en) * 2006-06-29 2008-01-03 Carl Zeiss Meditec Ag Method and device for optical detection on the eye
WO2008076467A2 (en) * 2006-07-03 2008-06-26 Beth Israel Deaconess Medical Center, Inc. Intraoperative imaging methods
WO2008008797A2 (en) 2006-07-10 2008-01-17 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
WO2008008917A2 (en) * 2006-07-12 2008-01-17 Mayo Foundation For Medical Education And Research Hydroxyapatite particles
CA2695147A1 (en) * 2006-08-03 2008-02-07 Beth Israel Deaconess Medical Center, Inc. Dyes and precursors and conjugates thereof
WO2008060833A2 (en) * 2006-10-24 2008-05-22 The Research Foundation Of State University Of New York Composition, method, system, and kit for optical electrophysiology
JP5643514B2 (en) 2007-02-09 2014-12-17 ビセン メディカル， インコーポレイテッド Polycyclo dyes and uses thereof
WO2008109832A2 (en) * 2007-03-08 2008-09-12 Visen Medical, Inc. Viable near-infrared fluorochrome labeled cells and methods of making and using same
GB0708507D0 (en) 2007-05-02 2007-06-13 Queen Mary & Westfield College Substituted phosphonates and their use
US20110262354A1 (en) 2007-07-13 2011-10-27 Emory University Cyanine-containing compounds for cancer imaging and treatment
ES2535958T3 (en) 2008-01-18 2015-05-19 Visen Medical, Inc. Fluorescent Imaging Agents
CN102099059B (en) * 2008-06-13 2015-09-23 西塞医疗中心 Small molecule ligand-drug conjugates for targeted cancer therapy
US20100092389A1 (en) * 2008-10-10 2010-04-15 The General Hospital Corporation Detection of atherosclerosis using indocyanine green
US9273059B2 (en) 2009-08-24 2016-03-01 Lumiphore, Inc. Macrocyclic HOPO chelators
WO2011079291A1 (en) * 2009-12-24 2011-06-30 Lumiphore, Inc. Radiopharmaceutical complexes
US8623324B2 (en) * 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
US20120059310A1 (en) * 2010-09-07 2012-03-08 Rao Papineni Vibration induced in vivo substance targeting
IT1403567B1 (en) 2011-01-21 2013-10-31 Univ Palermo POLYMERIC VECTORS OF POLYASPARTAMID CONJUGATED TO BISPHOSPHONATES FOR THE DIRECTION OF DRUGS TO BONES.
EP2707102B1 (en) 2011-05-09 2019-11-13 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same
WO2013148319A1 (en) 2012-03-30 2013-10-03 Visen Medical, Inc. Bacterial imaging agents and methods of using same
WO2014028057A1 (en) 2012-08-15 2014-02-20 Visen Medical, Inc. Prostate specific antigen agents and methods of using same for prostate cancer imaging
GB201306627D0 (en) 2013-04-11 2013-05-29 Thompson Richard Marker
JP6580552B2 (en) 2013-03-15 2019-09-25 ビセン メディカル， インコーポレイテッド 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dye and use thereof
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
AU2014228504C1 (en) 2013-03-15 2019-10-03 Visen Medical, Inc. Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection
US9846167B2 (en) 2013-03-26 2017-12-19 Lawson Health Research Institute Method for detecting and monitoring bone loss
WO2015066296A1 (en) 2013-10-31 2015-05-07 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
SG10201804505VA (en) 2013-10-31 2018-07-30 Beth Israel Deaconess Medical Ct Inc Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
US20180362559A1 (en) * 2015-09-21 2018-12-20 University Of Southern California Bone active nitrogen-containing bisphosphonates with a near infrared fluorescent label
WO2017123806A1 (en) * 2016-01-12 2017-07-20 Cedars-Sinai Medical Center A method of non destructive monitoring of biological processes in microfluidic tissue culture systems
CA3013357A1 (en) 2016-02-01 2017-08-10 Cedars-Sinai Medical Center Systems and methods for growth of intestinal cells in microfluidic devices
US10682597B2 (en) 2016-04-14 2020-06-16 Baldwin Filters, Inc. Filter system
WO2018039030A1 (en) 2016-08-23 2018-03-01 University Of Maryland, Baltimore Methods for detecting and/or predicting age-related macular degeneration and/or alzheimer's disease
WO2018140647A1 (en) 2017-01-25 2018-08-02 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
US11767513B2 (en) 2017-03-14 2023-09-26 Cedars-Sinai Medical Center Neuromuscular junction
US11414648B2 (en) 2017-03-24 2022-08-16 Cedars-Sinai Medical Center Methods and compositions for production of fallopian tube epithelium
US10852236B2 (en) * 2017-09-12 2020-12-01 Curadel, LLC Method of measuring plant nutrient transport using near-infrared imaging
CN108344738B (en) * 2018-01-22 2021-07-27 翰飞骏德（北京）医疗科技有限公司 Imaging method for hydroxyapatite and device thereof
US12161676B2 (en) 2018-03-23 2024-12-10 Cedars-Sinai Medical Center Methods of use of islet cells
US10952616B2 (en) 2018-03-30 2021-03-23 Canon U.S.A., Inc. Fluorescence imaging apparatus
US11981918B2 (en) 2018-04-06 2024-05-14 Cedars-Sinai Medical Center Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
JP7464532B2 (en) 2018-04-06 2024-04-09 シーダーズ－サイナイ メディカル センター Neurodegenerative disease models derived from human pluripotent stem cells on a microfluidic chip
US10743749B2 (en) 2018-09-14 2020-08-18 Canon U.S.A., Inc. System and method for detecting optical probe connection
WO2021170781A1 (en) * 2020-02-28 2021-09-02 Technische Universität Berlin Fluorescent probes for detection of calcifications
US12440585B2 (en) 2023-09-12 2025-10-14 Curadel Surgical Innovations, Inc. Zwitterionic metal chelators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453505A (en) 1994-06-30 1995-09-26 Biometric Imaging, Inc. N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels
DE4445065A1 (en) 1994-12-07 1996-06-13 Diagnostikforschung Inst Methods for in-vivo diagnostics using NIR radiation
DE19649971A1 (en) 1996-11-19 1998-05-28 Diagnostikforschung Inst Optical diagnostics for the diagnosis of neurodegenerative diseases using near-infrared radiation (NIR radiation)
US6027709A (en) * 1997-01-10 2000-02-22 Li-Cor Inc. Fluorescent cyanine dyes
EP0979107A1 (en) 1997-04-29 2000-02-16 Nycomed Imaging As Light imaging contrast agents
ES2213899T3 (en) 1997-04-29 2004-09-01 Amersham Health As CONTRAST AGENTS USED IN IMAGE FORMATION TECHNIQUES BASED ON LIGHT.
US6214812B1 (en) * 1998-04-02 2001-04-10 Mbc Research, Inc. Bisphosphonate conjugates and methods of making and using the same
JP2000095758A (en) * 1998-09-18 2000-04-04 Schering Ag Near-infrared, fluorescent contrast medium, and its production
WO2002038190A2 (en) * 2000-10-27 2002-05-16 Beth Israel Deaconess Medical Center Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
JP5643514B2 (en) * 2007-02-09 2014-12-17 ビセン メディカル， インコーポレイテッド Polycyclo dyes and uses thereof
US8431714B2 (en) * 2007-04-16 2013-04-30 University Of Southern California Synthesis of drug conjugates via reaction with epoxide-containing linkers

Also Published As

Publication number Publication date
US6869593B2 (en) 2005-03-22
EP1341557A2 (en) 2003-09-10
US20060002857A1 (en) 2006-01-05
US20110256065A1 (en) 2011-10-20
US20090123383A1 (en) 2009-05-14
WO2002038190A3 (en) 2002-08-29
US20040028611A1 (en) 2004-02-12
WO2002038190A2 (en) 2002-05-16
US7374746B2 (en) 2008-05-20
US20070036724A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
AU2002236683A1 (en) Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
IL154031A0 (en) Substituted sulfonylaminomethylbenzoic acid derivatives and preparation
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
IL147924A0 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
HUP0201633A3 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001245316A1 (en) Naphtalene derivatives and their pharmaceutical use
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
AU2002246655A1 (en) Compositions and methods for detecting proteolytic activity
AU2001276027A1 (en) Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
AU2001292122A1 (en) Heterocyclic derivatives useful as pharmaceutical agents
AU2001247196A1 (en) Methods and compositions for detection of disease
AU2002224471A1 (en) In vivo stimulation of angiogenic activity
TW543376U (en) Physiological pant
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
AR025731A1 (en) "DITIEPINO [6,5-B] BENZO-FUSIONATED PYRIDINS AND RELATED COMPOSITIONS AND METHODS"
AU2001251004A1 (en) Detection of viable agents
AU7879600A (en) Interferometric residual-stress analysis
AUPQ015299A0 (en) Ph probe
IL147103A0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU3863900A (en) Prolyl peptidases and methods of use
AU2001259564A1 (en) Pharmaceutical compositions and methods for use